Biotechnology touches nearly every major industry today, from the medicines you take to the food on your plate to the cosmetics on your shelf. While most people associate it with healthcare, the reality is far broader. At least seven distinct fields rely on biotechnology as a core part of how they operate, and the list keeps growing as gene-editing tools and computational power become cheaper and more precise.
Medicine and Drug Development
Healthcare is the most prominent user of biotechnology, and the field has accelerated dramatically in the past five years. The COVID-19 mRNA vaccines from Pfizer-BioNTech and Moderna achieved efficacy rates above 90%, proving that engineered genetic instructions could train the immune system faster than traditional vaccine methods. That same mRNA platform is now being applied to vaccines for HIV, influenza, RSV, and rabies, with several in clinical trials. Moderna’s RSV vaccine (mRESVIA) has already been approved for older adults.
Cancer treatment is another major frontier. mRNA-based vaccines targeting melanoma, kidney cancer, glioblastoma, and acute myeloid leukemia have shown active immune responses in trials. Beyond vaccines, biotechnology enables gene therapy for inherited conditions like hemophilia, cystic fibrosis, and rare metabolic disorders such as Fabry disease. Researchers deliver functional mRNA into cells so the body can produce proteins it otherwise can’t make on its own.
Gene-editing tools like CRISPR-Cas9 add another layer. In cancer treatment, CRISPR is being used to engineer immune cells that are better at recognizing and attacking tumors. Scientists can simultaneously disable multiple genes that normally act as brakes on immune cells, making them more effective against hard-to-treat cancers.
Agriculture and Food Production
Farmers and food producers rely on biotechnology to grow crops that survive harsher conditions and need fewer chemical inputs. Gene-editing techniques have produced rice varieties with improved salt tolerance, maize with enhanced drought resistance, and wheat engineered to use nitrogen more efficiently. These aren’t distant lab experiments. Edited rice, maize, wheat, tomato, and cotton varieties have all been developed and tested in field conditions.
The goals go beyond just keeping plants alive. Biotechnology is used to boost nutritional content (increasing flavone levels in maize, for example), reduce unwanted compounds like heavy metals in rice, and even change starch composition to improve cooking quality. Older techniques like RNA interference have produced corn with built-in pest resistance, reducing the need for chemical insecticides. One persistent challenge is that some edited crops perform differently across climates: RNAi-edited rice showed strong results in temperate Asian environments but only 30 to 40% efficiency in tropical regions, highlighting how much local conditions still matter.
Industrial Manufacturing and Environmental Cleanup
Industrial biotechnology, sometimes called “white biotechnology,” uses living organisms or their enzymes to manufacture chemicals, materials, and fuels. Engineered microbes now function as tiny factories, converting raw materials into products that previously required petroleum-based chemistry. Hexanoic acid, produced by microorganisms through fatty acid pathways, serves as a platform chemical for antimicrobial agents, lubricants, fragrances, pharmaceuticals, and biofuels.
One of the most promising areas is plastic waste. Researchers have identified microorganisms that secrete enzymes capable of breaking down plastics into simpler chemical building blocks like acids, alcohols, and carbon-ring compounds. Rather than just degrading the plastic, scientists are engineering these microbes to convert the breakdown products into valuable materials: biosurfactants for cosmetics, vanillin precursors for the food industry, antioxidants for the oil sector, and even new biodegradable plastics. Engineered strains of E. coli, for instance, can now produce polylactic acid (a compostable plastic) from lactic acid. The long-term goal is a circular plastic economy where waste plastic becomes feedstock for new products.
Marine Biotechnology
The ocean is a vast source of bioactive compounds, and marine biotechnology extracts and applies them across several industries. Seaweeds, jellyfish, sea cucumbers, sponges, and microalgae produce molecules with properties that are difficult to replicate synthetically.
In cosmetics, marine-derived ingredients are already widely used. Alginate from seaweed acts as a gelling agent and promotes wound healing. Chitin from crustacean shells works as a skin moisturizer. Fucoidan, a polysaccharide from brown algae, shows anti-aging and skin-brightening effects. Astaxanthin, a red pigment from microalgae, is one of the most potent natural antioxidants and protects skin from UV damage. Omega-3 fatty acids like DHA and EPA, sourced from marine organisms, appear in anti-aging and wound-healing formulations. Even compounds from jellyfish venom, including collagen and specific proteins, are being explored for biomedical materials and food supplements.
Marine organisms also produce natural UV-blocking compounds called mycosporine-like amino acids, which function as biological sunscreens. These are extracted from red algae and cyanobacteria and incorporated into photoprotective skincare products. Ascidians (sea squirts) accumulate heavy metals as a chemical defense, a property researchers are studying for potential applications in aquaculture, where controlling microbial infections without antibiotics is a growing priority.
Forensic Science and Legal Identification
DNA profiling is one of biotechnology’s most familiar applications outside of medicine. Forensic labs use short tandem repeat (STR) analysis to create genetic profiles from biological evidence found at crime scenes. These profiles can connect suspects to locations, verify family relationships, establish biological parentage in civil cases, and identify disaster victims.
The technology works in both directions for justice. DNA typing provides evidence to prosecute criminals and, equally important, to exonerate people who have been wrongly accused or convicted. In countries like India, DNA profiling is now standard in both criminal cases (as corroborative evidence) and civil cases involving disputed parentage or kinship.
Bioinformatics and Computational Biology
Modern biotechnology generates enormous amounts of data, and bioinformatics is the field that makes sense of it. The Human Genome Project, completed in 2003 after mapping 3 billion base pairs and roughly 30,000 protein-coding genes across 46 chromosomes, launched bioinformatics into its current central role. Today, computational tools accelerate nearly every stage of drug development: identifying which genes to target, screening millions of candidate compounds, predicting side effects, and forecasting drug resistance before a molecule ever enters a clinical trial.
Computer-aided drug design helps researchers narrow down promising compounds faster and at lower cost than traditional lab screening alone. Structure-based methods model how a drug molecule physically fits into its target protein, filtering out poor candidates early. Artificial intelligence is increasingly layered on top of these tools, though accurately identifying drug targets at low cost with AI remains an active challenge rather than a solved problem.
How These Fields Are Regulated
In the United States, biotechnology products fall under a shared regulatory system involving three agencies: the FDA, the EPA, and the USDA. This structure, called the Coordinated Framework for the Regulation of Biotechnology, was first established in 1986 and most recently updated in 2017. The FDA oversees drugs, biologics, and food safety. The EPA regulates biotechnology products that interact with the environment, such as pest-resistant crops. The USDA handles agricultural products, including genetically modified organisms used in farming.
In 2022, an executive order directed all three agencies to streamline and clarify their oversight, acknowledging that the pace of biotechnology innovation had outrun the existing regulatory framework. The goal is to reduce approval timelines while maintaining safety standards, particularly for newer products like gene-edited crops and engineered microorganisms that don’t fit neatly into categories designed decades ago.